News of the WeekClinical Research

Testing a Novel Strategy Against Parkinson's Disease

See allHide authors and affiliations

Science  30 Mar 2007:
Vol. 315, Issue 5820, pp. 1778
DOI: 10.1126/science.315.5820.1778

You are currently viewing the summary.

View Full Text

Summary

One of the largest clinical trials ever for Parkinson's disease, announced last week by the National Institute of Neurological Disorders and Stroke, is experimental in more ways than one, officials say. Both its approach and the method of selecting the test agent, a supposed energy booster called creatine, are unorthodox. (Read more.)